B. Acham-Roschitz

发表

Do Children and Adolescents With Type 1 Diabetes Mellitus Have a Higher Frequency of Parietal Cell Antibodies Than Healthy Controls?

A. Deutschmann, B. Obermayer-Pietsch, U. Demel, 2011, Journal of pediatric gastroenterology and nutrition.

Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.

P. Zipfel, C. Mache, V. Frémeaux-Bacchi, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities

L. Weber, B. Tönshoff, L. Pavicic, 2022, Journal of inherited metabolic disease.

Bone and mineral metabolism in children with nephropathic cystinosis compared to other CKD entities.

L. Weber, B. Tönshoff, D. Haffner, 2020, The Journal of clinical endocrinology and metabolism.

A novel mutation of the RRM2B gene in an infant with early fatal encephalomyopathy, central hypomyelination, and tubulopathy.

F. Lindbichler, C. Mache, B. Plecko, 2009, Molecular genetics and metabolism.

Screening for haemorrhagic disorders in paediatric patients by means of a questionnaire

W. Muntean, M. Novak, I. Musić, 2009, Hämostaseologie.

An innovative local treatment for staphylococcal scalded skin syndrome

E. Mueller, M. Trop, T. Petnehazy, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Nephropathia Epidemica (Puumala Virus Infection) in Austrian Children

C. Mache, W. Zenz, E. Ring, 2010, The Pediatric Infectious Disease Journal.

Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.

A. Boulesteix, W. Gahl, B. Tönshoff, 2022, Molecular genetics and metabolism.

Chest configuration in children and adolescents with infantile nephropathic cystinosis compared with other chronic kidney disease entities and its clinical determinants.

L. Weber, B. Tönshoff, L. Pavicic, 2023, Pediatric nephrology.